The Division of Cancer Prevention at the National Cancer Institute, National Institutes of Health invite you to attend the NCI Division of Cancer Prevention (DCP) Investigators and Site Coordinators Opportunity for Research (I-SCORE 2022), which will take place March 31 – April 1, 2022.
These two half-day learning sessions is designed specifically The Division of Cancer Prevention conducts Phase 0/I/II cancer prevention clinical trials through its Consortia for Early Phase Prevention Trials program. The purposes of the conference are: • To stimulate information sharing and collaborations among DCP staff, and consortia members including consortia coordinators, and consortia investigators • To develop strategies to enhance the value and operational efficiency of all aspects of the program including: a review of pre-clinical data to identify potential high-priority chemoprevention agents o Identification/discussion of novel agents, agent combinations Identification/discussion of intermediate endpoint biomarkers for early detection and for prevention; Discussion/establishment of DCP tissue biorepository; The use of social medial and other approaches to enhance accrual; Discussion of efficient/effective plans for monitoring all aspects of the trial including regulatory document, pharmacy, and chart review
To learn more about the practicum and to register, please visit
Event Contact Information:
Thank you,
Division of Cancer Prevention National Cancer Institute National Institutes of Health |
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Author | Trujillo, Elaine (NIH/NCI) [E] |
| File Modified | 0000-00-00 |
| File Created | 2022-02-01 |